Systemic Immune Response in Murine Bilateral Pheochromocytoma Model During Immunotherapy Based on a Combination of Mannan-BAM, TLR Ligands and Anti-CD40 Antibodies (MBTA Therapy)

Immunotherapy has become an essential component of cancer treatment, however, a majority of patients with solid metastatic cancers, such as pheochromocytoma (PHEO), do not respond to this type of therapy. Recently, we developed an intratumoral (i.t.) immunotherapy based on the unique combination of...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Endocr Soc
Main Authors: Uher, Ondrej, Huynh, Thanh-Truc, Zhu, Boqun, Horn, Lucas A, Medina, Rogelio, Wang, Herui, Palena, Claudia, Chmelar, Jindrich, Zhuang, Zhengping, Zenka, Jan, Pacak, Karel
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2021
Assuntos:
Tumor Biology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8089186/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.2113
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares